Ketamine Reduces Inflammation in Macrophages Stimulated by MRSA
Author Information
Author(s): Thomas Spentzas, Rebekah KH Shapley, Carlos Acuna Aguirre, Elizabeth Meals, Lauren Lazar, Mark S Rayburn, Brett S Walker, Keith B English
Primary Institution: University of Tennessee Health Science Center
Hypothesis
Ketamine can suppress macrophage TNF production in response to clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Conclusion
Ketamine inhibits TNF secretion by MRSA-stimulated RAW264.7 macrophages, likely through NMDA receptor antagonism.
Supporting Evidence
- Ketamine reduced TNF secretion by 18-34% in response to CA-MRSA.
- Both daptomycin and ketamine showed additive effects in reducing TNF secretion.
- NMDA receptor antagonists also inhibited TNF secretion similarly to ketamine.
Takeaway
Ketamine helps calm down the immune response in mice when they are infected with a type of bacteria that can cause serious illness.
Methodology
RAW264.7 macrophages were stimulated with CA-MRSA strains in the presence of antibiotics, and TNF secretion was measured after treatment with ketamine and NMDA receptor antagonists.
Limitations
The study was conducted in vitro, and the clinical significance of ketamine's effects in patients with sepsis needs further investigation.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website